Palisade Bio, Inc.
DE ˙ DB
SecurityDE:7NS0 / Palisade Bio, Inc.
InstitutionJane Street Group, Llc
Latest Disclosed Ownership410,761 shares
Latest Disclosed Value $ 718,832
Jane Street Group, Llc reports 19.52% increase in ownership of 7NS0 / Palisade Bio, Inc.

On May 12, 2026 - Jane Street Group, Llc filed a 13F-HR form disclosing ownership of 410,761 shares of Palisade Bio, Inc. (DE:7NS0) valued at $718,832 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 12, 2026 disclosing 343,686 shares of Palisade Bio, Inc.. This represents a change in shares of 19.52% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-12 2026-03-31 13F PALISADE BIO COM 696389402 410,761 67,075 19.52 719 -11.03 0.0000
2026-02-12 2025-12-31 13F PALISADE BIO COM 696389402 343,686 343,686 808 0.0001
2022-08-16 2022-06-30 13F PALISADE BIO COM 696389105 0 -36,223 -100.00 0 -100.00
2022-05-17 2022-03-31 13F PALISADE BIO COM 696389105 36,223 13,938 62.54 38 31.03 0.0000
2022-02-15 2021-12-31 13F PALISADE BIO COM 696389105 22,285 22,285 29 0.0000
2015-11-16 2015-09-30 13F NEURALSTEM COM 64127R302 0 -36,913 -100.00 0 -100.00
2015-08-14 2015-06-30 13F NEURALSTEM COM 64127R302 36,913 36,913 72 0.0005
2015-02-17 2014-12-31 13F NEURALSTEM COM 64127R302 0 -10,141 -100.00 0 -100.00
2014-11-14 2014-09-30 13F NEURALSTEM COM 64127R302 10,141 -155,948 -93.89 33 -95.29 0.0003
2014-08-14 2014-06-30 13F NEURALSTEM COM 64127R302 166,089 -131,603 -44.21 701 -43.79 0.0089
2014-05-15 2014-03-31 13F NEURALSTEM COM 64127R302 297,692 297,692 1,247 0.0138
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.